EPAS1 and pulmonary arterial hypertension: Multiple clinical studies have demonstrated that both HIF-1α and HIF-2α are broadly upregulated in the lungs and circulation of PAH patients, primarily originating from pulmonary arterial endothelial cells and smooth muscle cells.